Security key
82686Q101
Silence Therapeutics plc - Ordinary share, nominal value 0.05 GBP per share (SLN)
CUSIP: 82686Q101
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Ordinary share, nominal value 0.05 GBP per share
- Total 13F shares
- 19,229,837
- Total 13F value
- $101,780,933
- Share change
- +831,749
- SEC-reported price per share
- $5.50
- Number of holders
- 29
- Value change
- +$4,398,940
- Number of buys
- 14
- Number of sells
- 7
- Shares outstanding
- 141,918,771
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
29
Top holders
10
SLN full security history
Ownership snapshot
Full 13F holder table
Silence Therapeutics plc SEC filings
Silence Therapeutics plc company facts
Broader feeds
Ownership snapshot
Top reported holders of SLN - Silence Therapeutics plc - Ordinary share, nominal value 0.05 GBP per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lombard Odier Asset Manag...
Disclosed value leader
Lombard Odier Asset Manag...
Comparable rows
15/15
Latest evidence
31 Mar 2023
13F
Lead comparable stake: 2.8%
Showing 1-6 of 15 holder rows.
Quick read
Lombard Odier Asset Management (USA) Corp leads the comparable SEC ownership view at 2.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lombard Odier Asset Management (USA) Corp's linked filing trail.
Comparable ownership
Top 5
Lombard Odier Asset Management (U...
2.8%
Lombard Odier Asset Management (E...
2.3%
TCG Crossover Management, LLC
1.5%
Deep Track Capital, LP
1.4%
BVF INC/IL
1.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lombard Odier Asset Management (USA) Corp |
13F
Company
|
2.8%
|
$20,689,170
3,959,101 shares
|
— | 31 Mar 2023 |
| Lombard Odier Asset Management (Europe) Ltd |
13F
Company
|
2.3%
|
$20,419,111
3,293,405 shares
|
— | 31 Mar 2023 |
| TCG Crossover Management, LLC |
13F
Company
|
1.5%
|
$13,050,225
2,104,875 shares
|
— | 31 Mar 2023 |
| Deep Track Capital, LP |
13F
Company
|
1.4%
|
$12,099,796
1,951,580 shares
|
— | 31 Mar 2023 |
| BVF INC/IL |
13F
Company
|
1.1%
|
$9,352,179
1,508,416 shares
|
— | 31 Mar 2023 |
| Aquilo Capital Management, LLC |
13F
Company
|
0.92%
|
$8,135,845
1,312,233 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
29
Shares
19,229,837
Rows available
29
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
29
Q2 2023 holders
29
Holder diff
0
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|